Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
- Revenue in USD (TTM)1.36bn
- Net income in USD167.68m
- Incorporated1985
- Employees3.02k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LeMaitre Vascular Inc | 226.26m | 45.16m | 1.85bn | 651.00 | 41.54 | 5.34 | 33.73 | 8.20 | 1.98 | 1.98 | 9.90 | 15.38 | 0.4973 | 1.12 | 6.92 | 347,551.50 | 9.93 | 9.09 | 10.52 | 9.89 | 68.80 | 66.24 | 19.96 | 16.64 | 13.83 | -- | 0.3258 | 38.38 | 13.63 | 13.40 | 46.28 | 19.68 | 13.11 | 13.79 |
| LivaNova PLC | 1.28bn | -222.15m | 2.32bn | 2.90k | -- | 2.24 | -- | 1.82 | -4.09 | -4.09 | 23.37 | 18.97 | 0.5083 | 2.55 | 6.20 | 439,786.20 | -8.85 | -4.14 | -11.25 | -5.03 | 69.33 | 67.61 | -17.42 | -9.04 | 1.37 | -- | 0.3781 | -- | 8.66 | 2.94 | 260.39 | -- | 10.98 | -- |
| Warby Parker Inc | 795.09m | -14.24m | 2.85bn | 2.22k | -- | 8.04 | 85.74 | 3.58 | -0.1188 | -0.1188 | 6.53 | 2.92 | 1.25 | 6.77 | 602.34 | 358,473.40 | -2.23 | -16.02 | -2.75 | -21.00 | 55.26 | 56.59 | -1.79 | -13.26 | 2.30 | -- | 0.00 | -- | 15.16 | 15.80 | 67.74 | -- | 14.43 | -- |
| ICU Medical Inc | 2.42bn | -93.69m | 3.07bn | 15.00k | -- | 1.54 | 25.37 | 1.27 | -3.83 | -3.83 | 98.92 | 80.76 | 0.5713 | 2.45 | 15.31 | 161,339.50 | -2.21 | -0.2042 | -2.51 | -0.2306 | 35.11 | 33.82 | -3.87 | -0.3326 | 1.52 | 1.22 | 0.4365 | -- | 5.44 | 13.47 | -296.86 | -- | -3.18 | -- |
| DENTSPLY SIRONA Inc | 3.72bn | -908.00m | 3.14bn | 14.00k | -- | 1.56 | -- | 0.8456 | -4.54 | -4.54 | 18.48 | 10.09 | 0.5646 | 2.92 | 5.90 | 265,642.80 | -13.79 | -4.06 | -18.07 | -4.83 | 51.84 | 53.14 | -24.42 | -8.59 | 0.7619 | 6.78 | 0.5374 | -- | -4.34 | -1.17 | -589.39 | -- | 7.91 | 11.28 |
| Procept Biorobotics Corp | 249.12m | -90.19m | 3.26bn | 756.00 | -- | 8.37 | -- | 13.09 | -1.70 | -1.70 | 4.69 | 7.04 | 0.5522 | 1.79 | 3.68 | 329,525.10 | -19.99 | -26.94 | -22.23 | -29.81 | 62.71 | 54.37 | -36.20 | -83.14 | 7.75 | -- | 0.1169 | -- | 64.84 | 105.21 | 13.68 | -- | -10.34 | -- |
| Envista Holdings Corp | 2.50bn | -1.12bn | 3.35bn | 12.30k | -- | 1.12 | -- | 1.34 | -6.53 | -6.53 | 14.49 | 17.70 | 0.4165 | 4.28 | 6.21 | 203,569.10 | -18.70 | -2.08 | -21.69 | -2.53 | 54.77 | 56.91 | -44.90 | -5.58 | 1.82 | 3.40 | 0.3174 | -- | -2.18 | 1.90 | -1,016.37 | -- | -15.36 | -- |
| Haemonetics Corp | 1.36bn | 167.68m | 3.53bn | 3.02k | 22.15 | 4.31 | 12.46 | 2.59 | 3.32 | 3.32 | 26.82 | 17.02 | 0.5857 | 1.76 | 6.65 | 450,156.80 | 7.22 | 5.41 | 8.90 | 6.55 | 55.87 | 53.20 | 12.32 | 9.18 | 0.9857 | 26.25 | 0.5987 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| Inspire Medical Systems Inc | 840.11m | 66.51m | 3.77bn | 1.25k | 58.69 | 5.93 | 50.09 | 4.49 | 2.18 | 2.18 | 27.58 | 21.57 | 1.19 | 1.73 | 10.19 | 674,246.40 | 9.39 | -4.83 | 10.38 | -5.43 | 84.65 | 84.59 | 7.92 | -5.12 | 7.44 | -- | 0.00 | -- | 28.49 | 57.80 | 352.96 | -- | 70.20 | -- |
| TransMedics Group Inc | 488.23m | 48.95m | 3.81bn | 728.00 | 86.43 | 14.29 | 53.87 | 7.80 | 1.30 | 1.30 | 13.37 | 7.87 | 0.6254 | 4.31 | 4.36 | 670,641.50 | 6.27 | -5.73 | 6.73 | -6.28 | 59.47 | 62.37 | 10.03 | -11.86 | 8.32 | 21.39 | 0.657 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Integer Holdings Corp | 1.75bn | 78.00m | 4.00bn | 11.00k | 53.92 | 2.49 | 20.83 | 2.29 | 2.13 | 2.10 | 49.33 | 46.05 | 0.5445 | 4.87 | 4.94 | 158,744.70 | 2.43 | 3.28 | 2.60 | 3.54 | 27.10 | 26.70 | 4.47 | 6.38 | 2.14 | 4.30 | 0.4396 | 0.00 | 10.35 | 6.41 | 35.80 | 5.82 | 16.99 | -- |
| Irhythm Technologies Inc | 618.59m | -98.32m | 4.33bn | 2.00k | -- | 49.99 | -- | 7.01 | -3.14 | -3.14 | 19.74 | 2.72 | 0.6739 | 12.97 | 7.26 | 309,293.50 | -10.71 | -20.12 | -12.08 | -24.37 | 69.39 | 68.61 | -15.89 | -23.90 | 5.58 | -- | 0.8819 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Merit Medical Systems Inc | 1.39bn | 122.26m | 5.00bn | 7.40k | 41.46 | 3.50 | 20.60 | 3.60 | 2.04 | 2.04 | 23.12 | 24.18 | 0.5792 | 2.34 | 7.30 | 187,615.80 | 5.10 | 3.49 | 5.54 | 3.93 | 47.80 | 45.37 | 8.81 | 5.65 | 3.26 | 24.20 | 0.3384 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| Teleflex Inc | 3.01bn | 149.53m | 5.02bn | 14.10k | 35.77 | 1.24 | 11.80 | 1.67 | 3.18 | 3.17 | 64.50 | 91.67 | 0.4112 | 2.10 | 6.59 | 213,485.40 | 2.04 | 4.58 | 2.23 | 5.01 | 55.68 | 54.77 | 4.97 | 11.38 | 1.32 | 7.59 | 0.3178 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Lantheus Holdings Inc | 1.54bn | 254.32m | 5.09bn | 808.00 | 20.89 | 4.37 | 16.06 | 3.31 | 3.52 | 3.52 | 21.62 | 16.84 | 0.7908 | 7.96 | 4.48 | 1,901,855.00 | 13.09 | 9.87 | 14.95 | 11.33 | 64.04 | 60.44 | 16.55 | 12.86 | 5.46 | -- | 0.3275 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
Data as of Jul 18 2025. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD
53.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2025 | 5.67m | 11.28% |
| The Vanguard Group, Inc.as of 31 Mar 2025 | 4.98m | 9.91% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2025 | 4.35m | 8.66% |
| Wellington Management Co. LLPas of 31 Mar 2025 | 2.43m | 4.84% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2025 | 2.20m | 4.37% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 1.92m | 3.82% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2025 | 1.58m | 3.14% |
| River Road Asset Management LLCas of 31 Mar 2025 | 1.40m | 2.78% |
| Geode Capital Management LLCas of 31 Mar 2025 | 1.22m | 2.43% |
| Royce & Associates LPas of 31 Mar 2025 | 1.16m | 2.31% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
